A major breakthrough in reducing the severity of multiple sclerosis (MS) has apparently been made by University of Bristol scientists.
In the study carried out on mice and human brain tissue, the researchers found that neuropeptide 'galanin' was resistant to the MS-like disease, experimental autoimmune encephalomyelitis (EAE).
Multiple Sclerosis
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses
Advertisement
"The results were really remarkable, rarely do you see such a dramatic effect as this," the Daily Express quoted Professor David Wynick, who works on the function of galanin in the relief of neuropathic pain, as saying.
"Mice with high levels of galanin just didn't develop any signs of disease," he added.
Although the researchers say that results are extremely "promising", they insist that lot more needs to be done to figure out how this works before a drug can be developed.
Source: ANI
RAS
Although the researchers say that results are extremely "promising", they insist that lot more needs to be done to figure out how this works before a drug can be developed.
Source: ANI
RAS
Chemotherapy
''Chemo'' means medicine or ''drug'', ''therapy'' means ''treatment''. Chemotherapy refers to the use of cytotoxic drugs in the treatment of cancer.
Advertisement
Multiple Sclerosis Now Reversible In MiceIn a breakthrough study, researchers have successfully reversed multiple sclerosis in mice with the help of a new experimental treatment. | Advertisement
|
Advertisement
Latest Research News
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
Autoimmune disorders were found to be linked to Sjogren's, systemic lupus erythematosus, and systemic sclerosis.
Successful brain pacemaker implantation has helped a 51year old Parkinson's disease patient to revitalize her quality of life.
Recent recommendations on lifestyle behaviors to prevent progression of rheumatic and musculoskeletal diseases revealed.